Hazard
1,031 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all contamination risk recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
UCB Biosciences is recalling CIMZIA (certolizumab pegol) prefilled syringes nationwide because of a lack of assurance of sterility. Affected lots are distributed across the US.
Medtronic is recalling certain lots of GUNDRY Retrograde Cannula (Model 94113T), a cardiopulmonary bypass catheter, due to potential sterile barrier breach in the product.
Medtronic is recalling certain lots of GUNDRY Retrograde Cannula (Model 94115T) cardiopulmonary bypass vascular catheters due to potential sterile barrier breach. The affected product has been distributed worldwide.
Medtronic is recalling certain lots of DLP Retrograde Cannula (Model 94913L), a cardiopulmonary bypass catheter, due to potential sterile barrier breaches. The affected device was distributed worldwide.
Stryker is recalling 449 reprocessed electrophysiology catheters due to incomplete seals that may compromise sterility. Units were distributed in the US, Israel, and Canada.
Stryker Sustainability Solutions is recalling BARD Dynamic Tip Steerable reprocessed electrophysiology catheters (Product Number 200344) due to incomplete seals on sterile product packaging that could compromise sterility.
Stryker Sustainability Solutions is recalling three lots of Daig Livewire Steerable reprocessed electrophysiology catheters due to incomplete seals on the sterile packaging. The defect affects units distributed in the US, Israel, and Canada.
Medline is recalling multiple convenience kits used in catheterization labs and surgical procedures due to calibration issues with sterilization equipment that may affect sterility assurance. The affected kits were distributed nationwide.
Fresenius Medical Care is recalling DELFLEX Dextrose Peritoneal Dialysis Solution bags due to potential leaks from bag perforations that could compromise sterility. Affected patients should contact their healthcare provider immediately.
Medline Industries is recalling multiple Convenience Kits nationwide because sterilization equipment calibration issues may have compromised the sterility assurance level of the products, despite exposure to validated sterilization cycles.
Medline Industries is recalling over 7,700 surgical convenience kits due to calibration issues with sterilization and packaging equipment that may affect the sterility assurance level of the products.
Medline is recalling certain Dental Pack and Surgical Pack convenience kits due to calibration issues with sterilization equipment that may affect sterility assurance. Approximately 3,508 units were distributed nationwide.
Medline is recalling Convenience Kits due to calibration issues with sterilization equipment that may affect the sterility assurance level of the products.
B. Braun Medical Inc. is recalling Dextrose Injection USP 70% in 2000 mL bags nationwide due to lack of assurance of sterility and potential leakage from the diaphragm port after foil removal.
Spectra Medical Devices is recalling 7,120,750 ampules of 0.9% Sodium Chloride Injection, USP, nationwide due to lack of sterility assurance. The product is used for intravenous, intramuscular, and subcutaneous injection.
Bupivacaine Hydrochloride injectable anesthetic is being recalled due to lack of assurance of sterility. Approximately 3.26 million ampules distributed nationwide are affected.
Huons Co., Ltd. is recalling Lidocaine Hydrochloride injection (1% 50mg/5mL) distributed nationwide due to lack of assurance of sterility. No illnesses have been reported.
Lidocaine Hydrochloride injection vials are being recalled nationwide because manufacturers cannot guarantee the product's sterility. All lots within expiration are affected.
Fresenius Kabi is recalling specific batches of 0.9% Sodium Chloride Injection because sterility cannot be assured. The affected batches were distributed nationwide, including Alaska and Puerto Rico.
Fresenius Kabi recalls 0.9% Sodium Chloride Injection due to lack of sterility assurance. Multiple batches distributed nationwide are affected; patients should contact their healthcare provider.
Cipla USA recalls Lanreotide Acetate Injection nationwide due to manufacturing deficiencies in visual inspection procedures affecting sterile assurance. No illnesses have been reported.
Fresenius Kabi recalled specific batches of 0.9% Sodium Chloride Injection due to lack of sterility assurance. Affected batches were distributed nationwide, Alaska, and Puerto Rico.
Cipla USA is recalling 54,583 units of Lanreotide Acetate injection (120 mg/0.5 mL) nationwide. The FDA identified deficiencies in visual inspection procedures at the contract manufacturing site that could compromise sterility assurance.
Fresenius Kabi USA, LLC is recalling sodium chloride 0.9% intravenous injections because the manufacturer cannot assure sterility. Affected batches were distributed nationwide and in Puerto Rico and Alaska.
Fresenius Kabi is recalling specific batches of 0.9% Sodium Chloride Injection due to lack of sterility assurance. The affected intravenous medication was distributed nationwide, including Alaska and Puerto Rico.